Back to top
more

athenahealth, Inc. (ATHN)

(Delayed Data from NSDQ)

$134.99 USD

134.99
NA

0.00 (0.00%)

Updated Feb 11, 2019 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Sweta Jaiswal, FRM headshot

Healthcare's Near-Term Prospects Bright: 3 ETFs in Focus

The healthcare space might have seen a sluggish year so far. But its valuation and near-term prospects make it a good space for investments right now.

Athenahealth (ATHN) Earnings Expected to Grow: Should You Buy?

Athenahealth (ATHN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Investors Should Retain athenahealth (ATHN) Stock

athenahealth (ATHN) gains from a broad product portfolio. However, it faces stiff competition in the MedTech space.

Cerner (CERN) Teams Up With Nebraska-Based LRHC, Shares Up

Cerner's (CERN) coveted Millennium platform has seen rising demand in recent times.

Integra LifeSciences Unveils Titan RSS-S, Widens Portfolio

The latest launch reflects Integra LifeSciences' (IART) consistent efforts to boost the Orthopedics and Tissue Technologies segment.

Integra (IART) Rises 5% on Robust Preliminary Q4 Results

Integra's (IART) total Q4 revenues are likely to be at the upper end of its prior guided range.

Boston Scientific Gains on Impressive Preliminary Q4 Results

Boston Scientific's (BSX) solid top line is expected to be backed by growth across all segments and geographical regions in Q4.

ResMed Announces Complete Mobi Launch in US Markets for COPD

ResMed (RMD) progresses with efforts to boost Respiratory Care suite.

QIAGEN Scores on Strategic Alliances, Suffers Low HPV Sales

QIAGEN (QGEN) pins high hopes on its strategic tie-ups with Hamilton and DiaSorin. It unveils a CE-marked DiaSorin automation solution in Europe to use the LIAISON system for test read-out.

Hologic Stock Rides on Impressive Preliminary Q1 Result

Hologic's (HOLX) strong top line is primarily expected on the back of balanced growth across a majority of the company's segments in Q1.

ResMed Closes Propeller Health Buyout, Boosts COPD Suite

ResMed (RMD) expects to boost the Respiratory Care suite with the recently-completed Propeller Health buyout.

Cardiovascular Systems Expands Portfolio Amid Stiff Rivalry

Cardiovascular Systems (CSII) continues to expand its portfolio to widen the company's reach. However, Cardiovascular Systems operating in a highly competitive environment is a concern.

Neogen's Canadian Lab Buyout to Boost Genomics Business

Neogen (NEOG) continues to adopt initiatives to boost the genomics business.

LabCorp Rides on Covance Business Amid Reimbursement Woes

Within Covance Drug Development business, LabCorp (LH) aims at reaping huge profits via expanded solutions and better operational skills.

AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife

AngioDynamics (ANGO) sees a solid fiscal second quarter; gains from strong segmental contributions.

Here's Why You Should Hold on to Cerner (CERN) Stock for Now

A bullish guidance for 2018 and a series of latest developments make Cerner (CERN) a promising investment pick.

Cerner (CERN) Collaborates With McKesson's CoverMyMeds

Cerner's (CERN) ePrescribe workflow solution is likely to partner with CoverMyMeds' RxBenefit Clarity solution for prescription price transparency.

Will Walgreens (WBA) Q1 Earnings Gain From Overall Strength?

Several planned developments, early benefits from new pharmacy contracts as well as increased volumes are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.

Cerner's (CERN) Millennium Picked by Mid-Valley Hospital

Cerner's (CERN) EHR platforms have seen a series of developments in recent times.

Sweta Jaiswal headshot

4 Medical Device Stocks That More Than Doubled in 2018

Here are four medical device stocks which have performed really well in 2018 and should be on investors' radar next year as well.

Sanghamitra Saha headshot

What Bargains? Play 5 Stocks With Rising P/E Instead

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Here's Why You Should Invest in athenahealth (ATHN) Now

A strong guidance and focus on big data-based health records system make athenahealth (ATHN) a solid investment pick.

athenahealth (ATHN) Q3 Earnings Beat, Bookings Down Y/Y

athenahealth's (ATHN) Business and Services unit sees a strong Q3; 2018 guidance maintained.

100-Year Anniversary of Armistice Day

100-Year Anniversary of Armistice Day

Mark Vickery headshot

Return of Merger Monday: ATHN, SAP & More

Two major buyouts dominate our morning headlines, and both have deep implications for their respective industries.